Article
Proximity labeling reveals unique and shared interactomes of unmodified and pyroglutamate amyloid beta in human hippocampus in Alzheimer’s disease
2026-05-17
Abstract excerpt
Amyloid plaques are a hallmark neuropathological feature of Alzheimer’s disease (AD), composed of insoluble amyloid beta (Aβ) peptide. Aβ undergoes post-translational modifications that alter their biophysical properties, aggregation kinetics, and neurotoxicity, creating a heterogeneous pool of species that differentially affect AD pathogenesis. Pyroglutamate-modified Aβ (pEAβ) is a particularly aggregation-prone...
Topics
Open a Topic to create a Post that cites this publication.
- Advanced Proteomics Techniques and Applications
- Alzheimer's disease research and treatments
- Biotin and Related Studies
- Cholinesterase and Neurodegenerative Diseases
- Genetic Neurodegenerative Diseases
- Mitochondrial Function and Pathology
- Parkinson's Disease Mechanisms and Treatments
- S100 Proteins and Annexins
Identifiers and source
- Literature Corpus work
- 973772a2-4249-5fe8-89bb-ed7afbb0d649
- DOI
- 10.64898/2026.05.13.724866
